Global Cord Blood Statistics
Share Statistics
Global Cord Blood has 133.91M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 133.91M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 5.92 and the forward
PE ratio is null.
Global Cord Blood's PEG ratio is
0.01.
| PE Ratio | 5.92 |
| Forward PE | n/a |
| PS Ratio | 2.39 |
| Forward PS | n/a |
| PB Ratio | 0.61 |
| P/FCF Ratio | 5 |
| PEG Ratio | 0.01 |
Financial Ratio HistoryEnterprise Valuation
Global Cord Blood has an Enterprise Value (EV) of -3.69B.
| EV / Sales | -2.97 |
| EV / EBITDA | -5.62 |
| EV / EBIT | -6.02 |
| EV / FCF | -6.22 |
Financial Position
The company has a current ratio of 10.73,
with a Debt / Equity ratio of 0.
| Current Ratio | 10.73 |
| Quick Ratio | 10.66 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 10.27% and Return on Invested Capital is 10.13%.
| Return on Equity | 10.27% |
| Return on Assets | 5.87% |
| Return on Invested Capital | 10.13% |
| Revenue Per Employee | $1,034,321.96 |
| Profits Per Employee | $416,859.4 |
| Employee Count | 1,202 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 4 |
Taxes
| Income Tax | 118.35M |
| Effective Tax Rate | 18.85% |
Stock Price Statistics
The stock price has increased by 0.08% in the
last 52 weeks. The beta is -0.04, so Global Cord Blood's
price volatility has been lower than the market average.
| Beta | -0.04 |
| 52-Week Price Change | 0.08% |
| 50-Day Moving Average | 2.95 |
| 200-Day Moving Average | 2.91 |
| Relative Strength Index (RSI) | 51.83 |
| Average Volume (20 Days) | 177,415 |
Income Statement
In the last 12 months, Global Cord Blood had revenue of 1.24B
and earned 501.06M
in profits. Earnings per share was 4.12.
| Revenue | 1.24B |
| Gross Profit | 1.06B |
| Operating Income | 608.87M |
| Net Income | 501.06M |
| EBITDA | 628.78M |
| EBIT | 589.27M |
| Earnings Per Share (EPS) | 4.12 |
Full Income StatementBalance Sheet
The company has 6.66B in cash and 147K in
debt, giving a net cash position of 6.66B.
| Cash & Cash Equivalents | 6.66B |
| Total Debt | 147K |
| Net Cash | 6.66B |
| Retained Earnings | 2.89B |
| Total Assets | 1.35B |
| Working Capital | 991.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 613.61M
and capital expenditures -19.79M, giving a free cash flow of 593.82M.
| Operating Cash Flow | 613.61M |
| Capital Expenditures | -19.79M |
| Free Cash Flow | 593.82M |
| FCF Per Share | 4.89 |
Full Cash Flow StatementMargins
Gross margin is 85.26%, with operating and profit margins of 48.97% and 40.3%.
| Gross Margin | 85.26% |
| Operating Margin | 48.97% |
| Pretax Margin | 50.5% |
| Profit Margin | 40.3% |
| EBITDA Margin | 52.83% |
| EBIT Margin | 48.97% |
| FCF Margin | 47.76% |
